Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Corydalis decumbens (Chinese name 夏天无, Xia Tian Wu) is a traditional Chinese medicinal herb known as Rhizoma Corydalis Decumbentis or Decumbent Corydalis Tuber. It is used in Traditional Chinese Medicine (TCM) primarily to decrease blood pressure, relieve spasm, promote the circulation of qi, alleviate pain, activate blood and dissipate blood stasis. Indications include hypertension, sciatica, polio syndrome sequelae (such as hemiplegia), rheumatic arthritis and limb numbness. The herb is typically administered as a decoction or powder and can also be formulated into tablets or pills[1][5]. Compound formulations such as Fufang Xiatianwu Pian are used for conditions like rheumatoid arthritis and sciatica[2][4]. The mechanism of action is not fully elucidated but involves vasodilation and anti-inflammatory effects according to pharmacological studies[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on corydalis decumbens.